Literature DB >> 31581341

Weather-informed Light-tissue Model-Based Dose Planning for Indoor Daylight Photodynamic Therapy.

Ethan P M LaRochelle1, Michael Shane Chapman2, Edward V Maytin3, Tayyaba Hasan4, Brian W Pogue1,2.   

Abstract

Daylight activation for photodynamic therapy (PDT) of skin lesions is now widely adopted in many countries as a less painful and equally effective treatment mechanism, as compared to red or blue light activation. However, seasonal daylight availability and transient weather conditions complicate light dose estimations. A method is presented for dose planning without placing a large burden on clinical staff, by limiting spectral measurements to a one-time site assessment, and then using automatically acquired weather reports to track transient conditions. The site assessment tools are used to identify appropriate treatment locations for the annual and daily variations in sunlight exposure for clinical center planning. The spectral information collected from the site assessment can then be integrated with real-time daily electronic weather data. It was shown that a directly measured light exposure has strong correlation (R2 : 0.87) with both satellite cloud coverage data and UV index, suggesting that the automated weather indexes can be surrogates for daylight PDT optical dose. These updated inputs can be used in a dose-planning treatment model to estimate photodynamic dose at depth in tissue. A simple standardized method for estimating light dose during daylight-PDT could help improve intersite reproducibility while minimizing treatment times.
© 2019 American Society for Photobiology.

Entities:  

Year:  2019        PMID: 31581341      PMCID: PMC7117968          DOI: 10.1111/php.13170

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  23 in total

1.  The wrist is a reliable body site for personal dosimetry of ultraviolet radiation.

Authors:  E Thieden; M S Agren; H C Wulf
Journal:  Photodermatol Photoimmunol Photomed       Date:  2000-04       Impact factor: 3.135

2.  A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.

Authors:  S R Wiegell; S Fabricius; I M Stender; B Berne; S Kroon; B L Andersen; C Mørk; C Sandberg; G B E Jemec; M Mogensen; K M Brocks; P A Philipsen; J Heydenreich; M Haedersdal; H C Wulf
Journal:  Br J Dermatol       Date:  2011-04-05       Impact factor: 9.302

3.  Ultraviolet radiation exposure during daylight Photodynamic Therapy.

Authors:  Luke J McLellan; Paul O'Mahoney; Marina Khazova; Michael Higlett; Sally H Ibbotson; Ewan Eadie
Journal:  Photodiagnosis Photodyn Ther       Date:  2019-05-19       Impact factor: 3.631

4.  Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.

Authors:  J-P Lacour; C Ulrich; Y Gilaberte; V Von Felbert; N Basset-Seguin; B Dreno; C Girard; P Redondo; C Serra-Guillen; I Synnerstad; M Tarstedt; A Tsianakas; A W Venema; N Kelleners-Smeets; H Adamski; B Perez-Garcia; M J Gerritsen; S Leclerc; N Kerrouche; R-M Szeimies
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-10-05       Impact factor: 6.166

5.  Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ.

Authors:  Ana Luiza Ribeiro de Souza; Ethan LaRochelle; Kayla Marra; Jason Gunn; Scott C Davis; Kimberley S Samkoe; M Shane Chapman; Edward V Maytin; Tayyaba Hasan; Brian W Pogue
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-10-14       Impact factor: 3.631

6.  Database of Absorption and Fluorescence Spectra of >300 Common Compounds for use in PhotochemCAD.

Authors:  Masahiko Taniguchi; Jonathan S Lindsey
Journal:  Photochem Photobiol       Date:  2018-02-13       Impact factor: 3.421

7.  Comparison of Blue and White Lamp Light with Sunlight for Daylight-Mediated, 5-ALA Photodynamic Therapy, in vivo.

Authors:  Kayla Marra; Ethan P LaRochelle; M Shane Chapman; P Jack Hoopes; Karina Lukovits; Edward V Maytin; Tayyaba Hasan; Brian W Pogue
Journal:  Photochem Photobiol       Date:  2018-05-16       Impact factor: 3.421

8.  Photodynamic Therapy for Actinic Keratoses: A Randomized Prospective Non-sponsored Cost-effectiveness Study of Daylight-mediated Treatment Compared with Light-emitting Diode Treatment.

Authors:  Noora Neittaanmäki-Perttu; Mari Grönroos; Toni Karppinen; Erna Snellman; Pekka Rissanen
Journal:  Acta Derm Venereol       Date:  2016-02       Impact factor: 4.437

9.  Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.

Authors:  Lynda Spelman; Diana Rubel; Dedee F Murrell; Jo-Ann See; Daniel Hewitt; Peter Foley; Robert Salmon; Delphine Kerob; Thierry Pascual; Stephen Shumack; Pablo Fernandez-Penas
Journal:  Australas J Dermatol       Date:  2015-03-31       Impact factor: 2.875

10.  Alternatives to Outdoor Daylight Illumination for Photodynamic Therapy--Use of Greenhouses and Artificial Light Sources.

Authors:  Catharina M Lerche; Ida M Heerfordt; Jakob Heydenreich; Hans Christian Wulf
Journal:  Int J Mol Sci       Date:  2016-02-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.